Tracee Ellis Ross has made her Broadway debut in the one-woman show "Every Brilliant Thing" at the Hudson Theatre in New York City.
The production is notable for its communal approach to storytelling, integrating audience members into the performance to reflect the play's focus on mental health. By involving the public, the show transforms a solo narrative into a shared experience, breaking the traditional barrier between the performer and the viewer.
Ross began her performance run on July 7, 2026 [1]. The production is scheduled to run through Aug. 9, 2026 [2]. During the limited engagement, the actress said she discussed the specific process of casting audience members to participate in the show each night.
Because the play addresses sensitive themes regarding mental health, the inclusion of the audience serves to make the environment feel more supportive and connected. This casting process ensures that the storytelling remains organic and communal, aligning with the intent of the script to foster a sense of collective empathy.
Ross is performing the piece as a solo act, though the participation of the crowd means she is not alone on stage. The use of the Hudson Theatre provides a centralized Broadway venue for this experimental approach to casting and performance.
“The production is notable for its communal approach to storytelling”
By integrating non-professional audience members into a Broadway production, Ross is utilizing a technique that prioritizes emotional authenticity over traditional theatrical distance. This approach aligns the production's form with its subject matter, using real-time human interaction to mirror the communal support systems necessary for managing mental health.
